Thermo Fisher Scientific Inc: updates and filings

TMONYSEHealthcare · Measuring & Controlling Devices, NEC

Price

$686.79

November 17, 2026Market cap $255B

What Ploutos Investor adds for Thermo Fisher Scientific

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from 2009
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 68 daysAround Jan 25, 2027 · for Q4 2026

last Oct 21, 2026next Jan 25, 2027

An estimate from when it has reported before, which has been regular. The company announces the date itself.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Feb 26, 2026 latest annualOct 30, 2026 latest quarterly
  • Nov 5, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Oct 30, 2026Officer or director change
    Form8-K
  • Oct 30, 2026Quarterly reportfor the period to Sep 26, 2026
    Form10-Q
  • Oct 21, 2026Results of operations
    Form8-K
  • Jul 31, 2026Quarterly reportfor the period to Jun 27, 2026
    Form10-Q
  • Jul 28, 2026Filing (amendment)
    Form144/A
  • Jul 23, 2026Results of operations
    Form8-K
  • Jun 23, 2026Employee stock plan reportfor the period to Dec 31, 2025
    Form11-K
  • May 28, 2026Conflict minerals report
    FormSD
  • May 26, 2026Shareholder vote
    Form8-K
  • May 11, 2026Additional annual meeting material
    FormDEFA14A
  • May 1, 2026Quarterly reportfor the period to Mar 28, 2026
    Form10-Q
  • Apr 30, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Apr 23, 2026Results of operations
    Form8-K
  • Apr 7, 2026Annual report to shareholdersfor the period to Dec 31, 2025
    FormARS
  • Apr 7, 2026Additional annual meeting material
    FormDEFA14A
  • Apr 7, 2026Annual meeting proxy statement
    FormDEF 14A
  • Mar 27, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Mar 24, 2026Other material events
    Form8-K
  • Feb 26, 2026Annual reportfor the period to Dec 31, 2025
    Form10-K
  • Feb 12, 2026Material agreement entered, other material events
    Form8-K
  • Jan 29, 2026Results of operations
    Form8-K
  • Jan 23, 2026One of its securities removed from an exchange (usually a matured note)
    Form25-NSE
  • Jan 21, 2026One of its securities removed from an exchange (usually a matured note)
    Form25-NSE
  • Jan 12, 2026Officer or director change
    Form8-K

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC since Feb 14, 1994: every report, 8-K, meeting and letter. Of its other filings (1,362 in all), the newest. Of its note and share prospectuses (424B, FWP), the newest 40 of 147.

The full analysis

What do Thermo Fisher Scientific's filings show?

The filings are where every one of Thermo Fisher Scientific's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.